Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Sep 21 2021

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-sep-21-2021-5

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 21, 2021, titled "Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Foam, 1%".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases